Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease
Clinical trial NCT02728115 · UNKNOWN
Trial details
- NCT number
- NCT02728115
- Sponsor
- Azidus Brasil
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-16
- Primary completion
- 2022-12-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.